New molecular aspects of cholestatic liver diseases;Neue molekulare aspekte cholestatischer lebererkrankungen

Zeitschrift fur Gastroenterologie

Volumn 37, Issue 7, 1999, Pages 639-647

  Trauner, M ^a   Fickert, P ^a   Stauber, R E ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Bile acids; Cholestasis; Hepatocyte; Transporters; Ursodeoxycholic acid

Indexed keywords

BILE ACID; CARRIER PROTEIN; URSODEOXYCHOLIC ACID;

CELL MEMBRANE TRANSPORT; CHOLESTASIS; GENETIC DISORDER; HUMAN; LIVER CELL; LIVER DISEASE; MOLECULAR BIOLOGY; NONHUMAN; REVIEW;

ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; BILIRUBIN; CARRIER PROTEINS; CHOLESTASIS; HUMANS; LIVER CIRRHOSIS, BILIARY; P-GLYCOPROTEINS; POINT MUTATION;

EID: 0032798666     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991; 14: 551-60
2. Boyer JL. Bile duct epithelium: Frontiers in transport physiology. Am J Physiol 1990; 270: G1-G5
3. Meier PJ, Eckhardt U, Schröder A, Hagenbuch B, Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997; 26: 1667-77
4. Müller M, Jansen PLM. Molecular aspects of hepatobiliary transport. Am J Physiol 1997; 272: G1285-G303
5. Müller M, Jansen PLM. The secretory function of the liver: New aspects of hepatobiliary transport. J Hepatol 1998; 28: 344-54
6. +/bile acid cotransporter. J Clin Invest 1994; 93: 1326-31
7. Kullak-Ublick GA, Hagenbuch B, Stieger B et al. Molecular and functional characterisation of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 1995; 109: 1274-82
8. Kullak-Ublick GA, Beuers U, Meier PJ, Domdey H, Paumgartner G. Assignment of the human organic anion transporting polypeptide (OATP) gene to chromosome 12p12 by fluorescence in situ hybridisation. J Hepatol 1996; 25: 985-7
9. Kullak-Ublick GA, Beuers U, Fahney C et al. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology 1997; 26: 991-7
10. Keppler D, Arias IM. Introduction: Transport across the hepatocyte canalicular membrane. FASEB J 1997; 11: 15-8
11. Ueda K, Clark DP, Chen CJ et al. The human multi-drug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem 1987; 262: 505-8
12. Van der Bliek AM, Kooiman PM, Schneider C, Borst PA. Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 1988; 71: 401-411
13. Büchler M, König J. Brom M et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996; 271: 15091-8
14. Taniguchi M, Wada M, Kohno K et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant humen cancer cell lines with decreased drug accumulation. Cancer Res 1996; 56: 4124-9
15. Gerloff T, Stieger B, Hagenbuch B et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273: 10046-50
16. Martinez-Anso E, Castillo JE, Diez J, Medina JF, Prieo J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 1994; 19: 1400-6
17. Phillips MJ, Poucell S, Oda M. Biology of disease: Mechanisms of cholestasis. Lab Invest 1986; 54: 593-608
18. Anderson JM. Leaky junctions and cholestasis: A tight correlation. Gastroenterology 1996; 110: 1662-74
19. Stieger B, Landmann L. Effects of cholestasis on membrane flow and surface polarity in hepatocytes. J Hepatol 1996; 24: 128-34
20. Trauner M. Molecular alterations of canalicular transport systems in experimental models of cholestasis: Possible functional correlations. Yale J Biol Med 1997; 70: 365-78
21. +/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996; 110: 199-209
22. Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 1996; 111: 193-8
23. Moseley RH, Wang W, Takeda H et al. Effect of endotoxin on bile acid transport in rat liver: A potential model for sepsis-associated cholestasis. Am J Physiol 1996; 271: G137-G46
24. Simon FR, Fortune J, Iwahasi M et al. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1997; 271: G1043-52
25. Trauner M, Gartung C, Schlosser SF, Boyer JL. Role of nitric oxide in the transcriptional regulation of bile acid transporters in endotoxin-induced cholestasis (Abstrakt). Gastroenterology 1996; 110: A1349
26. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin down-regulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 1998; 101: 2092-100
27. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol 1997; 27: 1051-6
28. Vos TA, Hooiveld GJEJ, Koning H et al. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter. mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology 1998; 28: 1637-44
29. Trauner M, Arrese M, Soroka CJ et al. The rat canalicular conjugate export pump (mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113: 255-64
30. Schrenk D, Gant TW, Preisegger KH et al. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993; 17: 854-60
31. Shneider BL, Fox VL, Schwarz KB et al. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology 1997; 25: 1176-83
32. Mozawa S, Miyazaki M, Tou III et al. Human MDR1 and MDR3 gene expression in the liver with obstructive jaundice (Abstrakt). Gastroenterology 1997; 112: A1349
33. Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993; 105: 572-8
34. Medina JF, Martinez-Anso E, Yazquez JJ, Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997; 25: 12-7
35. Sela-Herman S, Bull L, Lomri N et al. In search of a gene for hereditary cholestasis. Biochem Mol Med 1996; 59: 98-103
36. Bull LN, Carlton VEH, Stricker NL et al. Genetic and morphological findings in progressive familial intrahepatic cholestatis (Byler disease [PFIC-I] and Byler syndrome): Evidence for heterogeneity. Hepatology 1997; 26: 155-64
37. Carlton VEH, Knisely AS, Freimer AB. Mapping a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-p22, intrahepatic cholestasis region. Hum Mol Genet 1995; 4: 1049-53
38. Houwen RHJ, Baharloo S, Blankenship K et al. Genome screening by searching for shared segments: Mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet 1994; 8: 380-6
39. Bull LN, van Rijk MJT, Pawlikowska L et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998; 18: 219-24
40. Strautnieks SS, Kagalwalla AF, Tanner MS et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Amer J Hum Genet 1997; 61: 630-3
41. Strautnieks SS, Bull LM, Knisely AS et al. A gene encoding a liver-specilic ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-8
42. Deleuze JF, Jacquemin E, Dubuisson C et al. Defect of multidrug resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904-8
43. De Vree JML, Jacquemin E, Sturm E et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998; 95: 282-7
44. Jacquemin E, Hermans D, Myara A et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997; 25: 519-23
45. Borst P, Schinkel AH. What have we learnt thus far from mice with disrupted P-glycoprotein genes? Eur J Cancer 1996; 32A: 985-90
46. Dumoulin FL, Reichel C, Sauerbruch T, Spengler U. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol 1997; 26: 852-6
47. Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular isoform of the MRP gene encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996; 23: 1061-6
48. Paulusma CC, Kool M, Bosnia PJ et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997; 23: 1539-42
49. Keppler D, Kartenbeck J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. In: Boyer JL, Ockner RK (eds.). Progress in Liver Disease. Vol. 14, Philadelphia, WB Saunders, 1996, 55-67
50. Kadmon M, Kluenemann C, Bochme M et al. Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocycte into bile. Gastroenterology 1993; 104: 1507-14
51. Welsh MJ, Smith AK. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993; 73: 1251-4
52. Roberts SK, Ludwig J, LaRusso NF. The pathobiology of biliary epithelia. Gastroenterology 1997; 112: 269-79